| Enhertu 100 mg powder for concentrate for solution for infusion EU/1/20/1508/001 |
Trastuzumab Deruxtecan |
Daiichi Sankyo Europe GmbH |
— |
| Enjaymo 50 mg/mL solution for infusion EU/1/22/1687/001-002 |
Sutimlimab |
Recordati Rare Diseases |
— |
| Enrylaze 10 mg/0.5 mL solution for injection/infusion. EU/1/23/1747/001 |
Crisantaspase |
Jazz Pharmaceuticals Ireland Limited |
— |
| Enspryng 120 mg solution for injection in pre-filled syringe EU/1/21/1559/001 |
Satralizumab |
Roche Registration GmbH |
— |
| Entacapone Orion 200 mg film-coated tablets EU/1/11/708/001-004 |
Entacapone |
Orion Corporation |
— |
| Entacapone Teva 200 mg film-coated tablets EU/1/10/665/001-004 |
Entacapone |
Teva Pharma B.V. |
— |
| Entecavir Accord 0.5 mg film-coated tablets EU/1/17/1211/001-003 |
Entecavir |
Accord Healthcare S.L.U. |
— |
| Entecavir Accord 1 mg film-coated tablets EU/1/17/1211/004-006 |
Entecavir |
Accord Healthcare S.L.U. |
— |
| Entecavir Viatris 0.5 mg Film-coated tablet EU/1/17/1227/001-005 |
Entecavir |
Viatris Limited |
— |
| Entecavir Viatris 1 mg film-coated tablets EU/1/17/1227/006-010 |
Entecavir |
Viatris Limited |
— |
| Entresto 24 mg/26 mg film-coated tablets EU/1/15/1058/001 |
Sacubitril valsartan |
Novartis Europharm Limited |
— |
| Entresto 49 mg/51 mg film-coated tablets EU/1/15/1058/002-004 |
Sacubitril valsartan |
Novartis Europharm Limited |
— |
| Entresto 6 mg/6 mg granules in capsules for opening EU/1/15/1058/023 |
Sacubitril, Valsartan |
Novartis Europharm Limited |
— |
| Entresto 97 mg/103 mg film-coated tablets EU/1/15/1058/005-007 |
Sacubitril valsartan |
Novartis Europharm Limited |
— |
| Entyvio 108 mg solution for injection in pre-filled pen EU/1/14/923/005-007 |
Vedolizumab |
Takeda Pharma A/S |
— |
| Entyvio 108 mg solution for injection in pre-filled syringe EU/1/14/923/002-004 |
Vedolizumab |
Takeda Pharma A/S |
— |
| Entyvio 300 mg powder for concentrate for solution for infusion EU/1/14/923/001 |
Vedolizumab |
Takeda Pharma A/S |
— |
| Enurev Breezhaler 44 micrograms inhalation powder, hard capsules EU/1/12/789/001-006 |
Glycopyrronium bromide |
Novartis Europharm Limited |
— |
| Envarsus 0.75 mg prolonged-release tablets EU/1/14/35/001-003 |
Tacrolimus monohydrate |
Chiesi Farmaceutici S.p.A. |
— |
| Envarsus 1 mg prolonged-release tablets EU/1/14/35/004-006 |
Tacrolimus monohydrate |
Chiesi Farmaceutici S.p.A. |
— |
| Envarsus 4 mg prolonged-release tablets EU/1/14/35/007-009 |
Tacrolimus monohydrate |
Chiesi Farmaceutici S.p.A. |
— |
| Enwylma 120 mg solution for injection EU/1/25/1944/001 |
Denosumab |
Zentiva k.s. |
— |
| Enyglid 0.5 mg tablets EU/1/09/580/1-6 |
Repaglinide |
KRKA, d.d., Novo mesto |
— |
| Enyglid 1 mg tablets EU/1/09/580/7-12 |
Repaglinide |
KRKA, d.d., Novo mesto |
— |
| Enyglid 2 mg tablets EU/1/09/580/13-18 |
Repaglinide |
KRKA, d.d., Novo mesto |
— |
| Enzalutamide Viatris 40 mg Film-coated tablet EU/1/24/1842/001-003 |
Enzalutamide |
Viatris Limited |
— |
| Enzalutamide Viatris 80 mg Film-coated tablet EU/1/24/1842/004-006 |
Enzalutamide |
Viatris Limited |
— |
| Epclusa 150 mg/37.5 mg coated granules in sachet EU/1/16/1116/003 |
Sofosbuvir, Velpatasvir |
Gilead Sciences Ireland UC |
— |
| Epclusa 200 mg/50 mg coated granules in sachet EU/1/16/1116/004 |
Sofosbuvir, Velpatasvir |
Gilead Sciences Ireland UC |
— |
| Epclusa 200 mg/50 mg film-coated tablets EU/1/16/1116/002 |
Sofosbuvir |
Gilead Sciences Ireland UC |
— |
| Epclusa 400 mg/100 mg film-coated tablets EU/1/16/1116/001 |
Sofosbuvir, Velpatasvir |
Gilead Sciences Ireland UC |
— |
| Ephedrine Kabi 10 mg/mL solution for injection PA2059/086/002 |
Ephedrine hydrochloride |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Ephedrine Kabi 3 mg/mL solution for injection PA2059/086/001 |
Ephedrine hydrochloride |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Ephedrine Kabi 30 mg/mL solution for injection PA2059/086/003 |
Ephedrine hydrochloride |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Epidyolex 100 mg/ml oral solution EU/1/19/1389/001 |
CANNABIDIOL |
Jazz Pharmaceuticals Ireland Limited |
— |
| Epirubicin 2 mg/ml Solution for Injection PA22766/003/001 |
Epirubicin hydrochloride |
Seacross Pharma (Europe) Limited |
Not marketed |
| Epivir 10 mg/ml oral solution EU/1/96/015/002 |
Lamivudine |
ViiV Healthcare BV |
— |
| Epivir 150 mg film-coated tablets EU/1/96/015/001 |
Lamivudine |
ViiV Healthcare BV |
— |
| Epivir 300 mg film-coated tablets EU/1/96/015/003 |
Lamivudine |
ViiV Healthcare BV |
— |
| Eplerenone MSN 25 mg film-coated tablets PA23250/014/001 |
Eplerenone |
MSN Labs Europe Limited |
Not marketed |
| Eplerenone MSN 50 mg film-coated tablets PA23250/014/002 |
Eplerenone |
MSN Labs Europe Limited |
Not marketed |
| Epoetin alfa HEXAL 1 000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/411/1-2 |
Recombinant human erythropoietin alfa |
Hexal AG |
— |
| Epoetin alfa HEXAL 10 000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/411/15-16 |
Recombinant human erythropoietin alfa |
Hexal AG |
— |
| Epoetin alfa HEXAL 2 000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/411/3-4 |
Recombinant human erythropoietin alfa |
Hexal AG |
— |
| Epoetin alfa HEXAL 20 000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/411/21-22 |
Epoetin alfa |
Hexal AG |
— |
| Epoetin alfa HEXAL 3 000 IU/0.3 mL solution for injection in a pre-filled syringe EU/1/07/411/5-6 |
Recombinant human erythropoietin alfa |
Hexal AG |
— |
| Epoetin alfa HEXAL 30 000 IU/0.75 mL solution for injection in a pre-filled syringe EU/1/07/411/23-24 |
Epoetin alfa |
Hexal AG |
— |
| Epoetin alfa HEXAL 4 000 IU/0.4 mL solution for injection in a pre-filled syringe EU/1/07/411/7-8 |
Recombinant human erythropoietin alfa |
Hexal AG |
— |
| Epoetin alfa HEXAL 40 000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/411/25-26 |
Epoetin alfa |
Hexal AG |
— |
| Epoetin alfa HEXAL 5 000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/411/9-10 |
Recombinant human erythropoietin alfa |
Hexal AG |
— |